980% overall is pretty phenomenal too. They're highlighting the 3600% because it's a bigger number. Once they know exactly why some are responding better than others they can tailor the trial and blow away every other cancer drug out there for that subpopulation. If p = .0004 with that tiny patient population how many zeros will be added for a large cancer trial?